MEXILETINE (Namuscla®)
Clinical Indication
Symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders
Comments
In line with NICE TA748 this product should be used by specialist centres only. At the time of classification LLR is not a site of a specialist centre.
Date of classification
January 2020
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.